Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Cougar Biotechnology, Inc. (CGRB)
|
Add to portfolio |
|
|
|
| Price: |
$43.01
| | Metrics |
| OS: |
20.8
|
M
| |
-127
|
% ROE
|
| Market cap: |
$894
|
M
| |
-538
|
% ROIC
|
|
Net cash:
|
$75.8
|
M
| |
$3.65
|
per share
|
|
EV:
|
$818
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($78.6)
|
M
| |
|
|
|
EBIT
|
($78.9)
|
M
| |
|
|
| EPS |
($3.71)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-08 | May-14-08 | Dec-31-07 | Dec-31-06 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 52.9 | 95.1 | 27.3 | 6.7 |
| General and administrative | 10.0 | 23.6 | 6.8 | 3.9 |
| EBIT | -63.1 | -119.0 | -34.1 | -10.7 |
| Pre-tax income | -59.8 | -116.9 | -31.9 | -11.9 |
| Income taxes | 0.0 | -2.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 1.7% | 0.0% | 0.0% |
| Net income | -59.8 | -116.9 | -32.2 | -13.5 |
| |
| Diluted EPS | ($2.90) | | ($2.17) | ($3.10) |
| Shares outstanding (diluted) | 20.6 | | 14.9 | 4.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|